Finch Therapeutics Group, Inc. Common Stock
FNCH
FNCH: Finch Therapeutics Group Inc is a clinical-stage microbiome therapeutics company. It is leveraging Human-First Discovery platform to develop a novel class of orally administered biological drugs. It is developing novel therapeutics to deliver missing microbes and their clinically relevant biochemical functions to correct dysbiosis and the diseases that emerge from it. The lead product candidate is CP101 which delivers a complete microbiome and is being developed initially for the treatment of patients with recurrent Clostridioides difficile infection.
moreShow FNCH Financials
Recent trades of FNCH by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by FNCH's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Jan. 03, 2023
-
Patent Title: Compositions and methods for treating diverticulitis and related disorders Dec. 20, 2022
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Nov. 22, 2022
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Nov. 08, 2022
-
Patent Title: Compositions and methods for treating parkinson's disease (pd) and related disorders Sep. 06, 2022
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Aug. 30, 2022
-
Patent Title: Microbiome related immunotherapies Jun. 07, 2022
-
Patent Title: Compositions and method for treating primary sclerosing cholangitis and related disorders Jan. 04, 2022
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Dec. 28, 2021
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Nov. 16, 2021
-
Patent Title: Methods and compositions for treating ulcerative colitis Nov. 09, 2021
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Sep. 28, 2021
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and device for delivering them Sep. 21, 2021
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Aug. 31, 2021
-
Patent Title: Methods for treating ulcerative colitis Jul. 27, 2021
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Jul. 20, 2021
-
Patent Title: Compositions and methods for treating diverticulitis and related disorders Jun. 22, 2021
-
Patent Title: Compositions and methods for treating multiple sclerosis and related disorders Jun. 08, 2021
-
Patent Title: Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them Apr. 27, 2021
Federal grants, loans, and purchases
Followers on FNCH's company Twitter account
Number of mentions of FNCH in WallStreetBets Daily Discussion
Recent insights relating to FNCH
Recent picks made for FNCH stock on CNBC
ETFs with the largest estimated holdings in FNCH
Flights by private jets registered to FNCH